Delivery Order SPE2DB22D1106-SPE2DB25FFEW1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,136.93 to AmerisourceBergen Drug Corp for the supply of Doxycycline Monohydrate 100 mg capsules in unit-dose packaging of 30 tablets. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and completed on July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply arrangement. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,369.59 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (500 count) under a firm fixed price contract type. The award, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive set-aside delivery order fulfilled from the vendor's existing contract vehicle. Performance will be completed at AmerisourceBergen's corporate office location in...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 500 units, with a contract ceiling value of $2,077.68. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,460.00 with firm fixed pricing and an ultimate completion date of July 24, 2025. The pharmaceutical products will be performed and delivered from the contractor's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Doxycycline Hyclate, an antibiotic medication. This firm fixed-price delivery order, valued at $4,243.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and extends through December 2026. The delivery order carries no...
- On July 21, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,268.75 to AmerisourceBergen Drug Corp for 1,000 tablets of Doxycycline Hyclate 100 mg. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 22, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Doxycycline Hyclate 100 mg capsules (500-count) with a ceiling value of $1,538.36. This firm fixed-price contract, which utilizes no set-aside designation, is scheduled for completion by August 8, 2025, with performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a $1,599.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Doxycycline Hyclate 100 mg, with a completion deadline of August 20, 2025. This non-set-aside competitive award was issued on August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units at a firm fixed price ceiling value of $2,952.00. This contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 500 units, with a contract value of $1,080.00. The award was made on July 29, 2025, with an ultimate completion date of July 30, 2025, under a firm fixed-price delivery order with no set-aside designation. Performance will occur at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFEW1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,884.22 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg capsules (500-count units). This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract carries no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of generic and brand-name medications, vaccines, and medical supplies to military healthcare systems globally. The company's federal contract portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 8/22/25 |